Skip to content
Activity & longevityCohort study6 min read

Older women who took more steps died less often, with gains levelling near 7,500 a day

MoveVitals Editorial Collective · Study published · Reading updated

Original paper:Association of Step Volume and Intensity With All-Cause Mortality in Older Women · JAMA Internal Medicine · 2019 · Original paper ↗

Key takeaway

Among 16,741 US women with a mean age of 72.0 years, mortality was lower in every higher step quartile than in the lowest (median 2,718 steps a day): hazard ratios were 0.59, 0.54 and 0.42 for medians of 4,363, 5,905 and 8,442. Mortality stopped falling at about 7,500 steps a day, and once total steps were accounted for, stepping intensity showed no significant link in the main comparisons. This is an observational study with a mean follow-up of 4.3 years, so it shows an association, not that walking more extends life.

Study design

Cohort study

Reading basis

Published abstract

Reading focus

Association & confounding

The research question

The goal of 10,000 steps a day is widely believed to be necessary for health, yet the authors note that it has limited scientific basis. It was also unknown whether stepping at a higher intensity is linked to health benefits over and above the number of steps taken. The researchers therefore tested how daily step count and several measures of stepping intensity relate to all-cause mortality in older women who wore an accelerometer for a week.

Who and how

This was a prospective cohort analysis within the Women's Health Study in the United States. Of 18,289 women who agreed to wear an accelerometer during waking hours for 7 days between 2011 and 2015, 17,708 returned their devices and data were downloaded successfully from 17,466. The analysis included the 16,741 who were compliant wearers (at least 10 hours a day on at least 4 days); their mean age was 72.0 years (SD 5.7).

Exposures were steps per day and four measures of stepping intensity: peak 1-minute cadence, peak 30-minute cadence, maximum 5-minute cadence, and time spent at 40 steps per minute or faster, which the authors treat as purposeful steps. The outcome was death from any cause, with 504 deaths during a mean follow-up of 4.3 years. Women were split into quartiles of daily steps, and hazard ratios compared each quartile with the least active one after adjustment for potential confounders; a spline analysis described the shape of the curve. For each intensity measure the highest quartile was compared with the lowest, first on its own and then after adjusting for steps per day. The analyses took place between 2018 and 2019. Full details of the method, including the device model, wear position, adjustment variables and statistical model, are not in the abstract.

What it found

  1. 1
    Women who took more steps had lower mortality than the least active quarter. Compared with the lowest quartile (median 2,718 steps a day), the adjusted hazard ratios were 0.59 (95% CI 0.47 to 0.75) for the second quartile (median 4,363), 0.54 (0.41 to 0.72) for the third (median 5,905) and 0.42 (0.30 to 0.60) for the fourth (median 8,442), with P < 0.01.
  2. 2
    The gain began at low step counts and flattened at the top. As few as about 4,400 steps a day was significantly related to lower mortality than about 2,700, and in the spline analysis the hazard ratios declined progressively with more steps until they levelled off at about 7,500 steps a day.
  3. 3
    Walking pace added little once total steps were counted. On their own, higher intensities were associated with significantly lower mortality, but after adjusting for steps per day all the associations weakened and most were no longer significant. For the highest versus the lowest quartile the hazard ratios were 0.87 (0.68 to 1.11) for peak 1-minute cadence, 0.86 (0.65 to 1.13) for peak 30-minute cadence, 0.80 (0.62 to 1.05) for maximum 5-minute cadence and 1.27 (0.96 to 1.68) for time at 40 steps per minute or faster (P > 0.05).
  4. 4
    Most of the day was spent at a standstill or close to it, and purposeful walking was a small share. The mean was 5,499 steps a day, and of wear time 51.4% was spent at 0 steps per minute, 45.5% at 1 to 39 steps per minute (incidental steps) and only 3.1% at 40 steps per minute or faster.

Limits & uncertainty

  1. 1
    In our reading, women who walk more also tend to differ in health and frailty. Adjusting for potential confounders cannot fully remove this, and with a mean follow-up of only 4.3 years, low step counts may partly reflect illness that was already present.
  2. 2
    Steps were measured during a single 7-day period between 2011 and 2015 and then linked to deaths over the following years, so the exposure may not reflect how much a woman walked earlier or later in life.
  3. 3
    The participants were older US women who agreed to wear a device, and those who did not wear it enough were left out; the abstract does not describe their race, ethnicity or health. The results should not be assumed to hold for men, younger women or other populations.
  4. 4
    The quartile comparisons rest on 504 deaths, and the highest quartile's median was 8,442 steps a day, so the data say little about much higher step counts. The 7,500 plateau is an approximate figure given without an interval.
  5. 5
    The intensity comparisons have wide confidence intervals that include 1, so they cannot rule out a modest benefit of faster stepping; they only show that no clear extra benefit was detected. This reading is based on the abstract only, which does not list the covariates or the other quartile contrasts.

What to take from it

In this group of older women, a modest rise from about 2,700 to about 4,400 steps a day was already linked to lower mortality, and the association did not need anything close to 10,000 steps: the curve levelled off at about 7,500. For someone starting from a low level, that suggests a realistic first aim is a step count a notch above current habits rather than a fixed number.

It does not show that adding steps will lower any one person's risk by these proportions, that steps beyond about 7,500 are pointless, or that pace never matters; the intensity measures lost their significant link once total steps were counted, but the confidence intervals were wide. The data come from older women and from observation rather than a trial, so they are suggestive rather than settled. Anyone with a medical condition or limited mobility should set activity goals with their clinician.

Reading your own data

Track daily steps as a weekly average from one device and compare your own multi-week trend rather than single days; the study used 7 days of wear and required at least 10 hours a day on at least 4 days, so a week with missed wear days is a weak data point. Pace measures such as peak 30-minute cadence are harder to read in consumer apps, and after accounting for total steps they showed no significant link here, so there is little reason to put them ahead of simply accumulating steps. Different devices count steps differently, and illness, travel or charging gaps will pull a week's average down.

How to read this evidence

Exposure precedes follow-up outcomes, but confounding and reverse causation can remain. A hazard ratio is not an individual absolute risk or a demonstrated intervention effect.

Sources & attribution

Association of Step Volume and Intensity With All-Cause Mortality in Older Women

JAMA Internal Medicine · 2019-05-29

DOI: 10.1001/jamainternmed.2019.0899 ↗PubMed · 31141585 ↗

MoveVitals editorial interpretation · educational content · no individual clinical review recorded

Sources checked 2026-11-01

Practical guides

Read in context

·Observational meta-analysis

7,000 steps a day linked to lower risk of death, heart disease and dementia than 2,000

Compared with 2000 steps a day, 7000 steps was associated with a hazard ratio of 0.53 (95% CI 0.46 to 0.60) for all-cause mortality across 14 studies, 0.75 (0.67 to 0.85) for cardiovascular disease and 0.62 (0.53 to 0.73) for dementia; cancer incidence was not significantly different (0.94, 0.87 to 1.01). Several outcomes rest on only two to four studies, and the certainty of evidence ranged from moderate to very low.

The Lancet Public Health

In-depth explainersRead study →
·Cohort study

Brief bursts of vigorous effort in daily life linked to lower mortality in non-exercisers

Among 25,241 UK Biobank adults who reported no leisure-time exercise, a median of 3 vigorous bouts of 1 or 2 minutes a day, picked up by a wrist accelerometer, was associated with a 38% to 40% lower risk of all-cause and cancer death and a 48% to 49% lower risk of cardiovascular death than no such bouts, over an average of 6.9 years and 852 deaths. This is an observational study using one week of wrist data and an algorithm to define vigorous effort, so it cannot show that adding such bursts causes the lower risk.

Nature Medicine

In-depth explainersRead study →
·Observational meta-analysis

Steps and mortality: gains flatten near 6,000–8,000 (age 60+) and 8,000–10,000 (under 60)

Pooling 15 cohorts (47,471 adults, 3,013 deaths, median follow-up 7.1 years), the second, third and fourth quartiles of daily steps (medians 5,801, 7,842 and 10,901) had hazard ratios for death of 0.60, 0.55 and 0.47 against the lowest quartile (median 3,553). The curve flattened at about 6,000 to 8,000 steps a day for adults aged 60 and over and 8,000 to 10,000 for younger adults. The data are observational, from a single week of step counting, mostly with waist-worn research devices.

The Lancet Public Health

In-depth explainersRead study →
·Observational meta-analysis

Accelerometers on 36,383 adults: any activity, even light, linked to lower mortality

In eight pooled cohorts (36,383 adults, mean age 62.6 years, 2,149 deaths over a median 5.8 years), the most active quarter by accelerometer-measured total activity had a mortality hazard ratio of 0.27 (95% CI 0.23 to 0.32) against the least active, and the most sedentary quarter had 2.63 (1.94 to 3.56). Light activity alone showed the same pattern, with 0.38 (0.28 to 0.51) in the top quarter. These are observational associations in adults aged 40 and over from the US and western Europe, so illness-driven inactivity and confounding cannot be excluded.

BMJ

In-depth explainersRead study →
Activity & longevity →